Xtx Topco LTD Seres Therapeutics, Inc. Transaction History

Xtx Topco LTD

$1.13 Billion
Q4 2024

A detailed history of Xtx Topco LTD transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 16,300 shares of MCRB stock, worth $13,203. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,300

Holding current value

$13,203

% of portfolio

0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$0.55 - $0.98 $8,965 - $15,974	16,300 New	16,300 $13,000
Q2 2024 Aug 12, 2024	SELL	$0.56 - $1.19 $29,993 - $63,736	-53,560 Reduced 70.76%	22,132 $15,000
Q1 2024 May 13, 2024	SELL	$0.75 - $1.56 $245,110 - $509,829	-326,814 Reduced 81.19%	75,692 $58,000
Q4 2023 Feb 13, 2024	BUY	$0.93 - $2.15 $234,740 - $542,679	252,409 Added 168.16%	402,506 $563,000
Q3 2023 Nov 13, 2023	BUY	$2.33 - $5.07 $349,726 - $760,991	150,097 New	150,097 $357,000
Q4 2022 Feb 14, 2023	BUY	$5.09 - $9.05 $141,013 - $250,721	27,704 Added 244.39%	39,040 $218,000
Q3 2022 Nov 14, 2022	BUY	$3.5 - $7.2 $39,676 - $81,619	11,336 New	11,336 $73,000
Q1 2022 May 13, 2022	SELL	$6.3 - $8.84 $73,004 - $102,437	-11,588 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$6.02 - $11.43 $78,109 - $148,304	-12,975 Reduced 52.82%	11,588 $97,000
Q3 2021 Nov 12, 2021	BUY	$5.46 - $22.6 $134,113 - $555,123	24,563 New	24,563 $171,000

Others Institutions Holding MCRB

# of Institutions

Shares Held

41.3M

Call Options Held

2.96M

Put Options Held

228K

Flagship Pioneering Inc. Cambridge, MA

23.1M
Shares

$18.7 Million
5.74% of portfolio
Vanguard Group Inc Valley Forge, PA

5.87M
Shares

$4.76 Million
0.0% of portfolio
Morgan Stanley New York, NY

2.01M
Shares

$1.63 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

1.81M
Shares

$1.47 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.76M
Shares

$1.43 Million
0.0% of portfolio

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $100M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Account